
RevBio Secures FDA Approval to Launch Dental Regenerative Bone Glue Trial
FDA Clears RevBio® to Begin Clinical Trial of Regenerative Bone Glue in Dentistry RevBio, a biomedical company focused on developing regenerative biomaterials, announced that it has received approval from the U.S. Food and Drug Administration (FDA) to initiate a pilot…












